KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unitedhealth (UNH) Current Deferred Revenue (2016 - 2025)

Unitedhealth (UNH) has disclosed Current Deferred Revenue for 17 consecutive years, with $3.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 2.89% to $3.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 billion, a 2.89% increase, with the full-year FY2025 number at $3.4 billion, up 2.89% from a year prior.
  • Current Deferred Revenue was $3.4 billion for Q4 2025 at Unitedhealth, up from $3.4 billion in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $15.3 billion in Q3 2023 to a low of $2.2 billion in Q2 2022.
  • A 5-year average of $5.2 billion and a median of $3.3 billion in 2024 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: soared 571.43% in 2023, then crashed 82.68% in 2024.
  • Unitedhealth's Current Deferred Revenue stood at $2.6 billion in 2021, then grew by 19.6% to $3.1 billion in 2022, then rose by 9.11% to $3.4 billion in 2023, then fell by 1.13% to $3.3 billion in 2024, then rose by 2.89% to $3.4 billion in 2025.
  • Per Business Quant, the three most recent readings for UNH's Current Deferred Revenue are $3.4 billion (Q4 2025), $3.4 billion (Q3 2025), and $3.0 billion (Q2 2025).